Phase II/III Clinical Trial of COVAXIN in Age Group of 2 to 18 Years Approved by DCGI
GG News Bureau
New Delhi, 13th May. After careful examination, the National Regulator of the country, the Drugs Controller General of India (DCGI), has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission…